title: A mouse model for pathogen-induced chronic inflammation at local and systemic sites.
abstract: Chronic inflammation is a major driver of pathological tissue damage and a unifying characteristic of many chronic diseases in humans including neoplastic, autoimmune, and chronic inflammatory diseases. Emerging evidence implicates pathogen-induced chronic inflammation in the development and progression of chronic diseases with a wide variety of clinical manifestations. Due to the complex and multifactorial etiology of chronic disease, designing experiments for proof of causality and the establishment of mechanistic links is nearly impossible in humans. An advantage of using animal models is that both genetic and environmental factors that may influence the course of a particular disease can be controlled. Thus, designing relevant animal models of infection represents a key step in identifying host and pathogen specific mechanisms that contribute to chronic inflammation. Here we describe a mouse model of pathogen-induced chronic inflammation at local and systemic sites following infection with the oral pathogen Porphyromonas gingivalis, a bacterium closely associated with human periodontal disease. Oral infection of specific-pathogen free mice induces a local inflammatory response resulting in destruction of tooth supporting alveolar bone, a hallmark of periodontal disease. In an established mouse model of atherosclerosis, infection with P. gingivalis accelerates inflammatory plaque deposition within the aortic sinus and innominate artery, accompanied by activation of the vascular endothelium, an increased immune cell infiltrate, and elevated expression of inflammatory mediators within lesions. We detail methodologies for the assessment of inflammation at local and systemic sites. The use of transgenic mice and defined bacterial mutants makes this model particularly suitable for identifying both host and microbial factors involved in the initiation, progression, and outcome of disease. Additionally, the model can be used to screen for novel therapeutic strategies, including vaccination and pharmacological intervention.
authors.affiliation: Department of Medicine, Section of Infectious Disease, Boston University School of Medicine.
authors.forename: George
authors.initials: G
authors.lastname: Papadopoulos
authors.affiliation: Department of Medicine, Section of Infectious Disease, Boston University School of Medicine.
authors.forename: Carolyn D
authors.initials: CD
authors.lastname: Kramer
authors.affiliation: Department of Medicine, Section of Infectious Disease, Boston University School of Medicine.
authors.forename: Connie S
authors.initials: CS
authors.lastname: Slocum
authors.affiliation: Department of Medicine, Section of Infectious Disease, Boston University School of Medicine.
authors.forename: Ellen O
authors.initials: EO
authors.lastname: Weinberg
authors.affiliation: Department of Biophysics, Boston University School of Medicine.
authors.forename: Ning
authors.initials: N
authors.lastname: Hua
authors.affiliation: Department of Medicine, Section of Infectious Disease, Boston University School of Medicine.
authors.forename: Cynthia V
authors.initials: CV
authors.lastname: Gudino
authors.affiliation: Department of Medicine, Section of Infectious Disease, Boston University School of Medicine.
authors.forename: James A
authors.initials: JA
authors.lastname: Hamilton
authors.affiliation: Department of Medicine, Section of Infectious Disease, Boston University School of Medicine; cgenco@bu.edu.
authors.forename: Caroline A
authors.initials: CA
authors.lastname: Genco
mesh_terms: D000818:Animals; D016866:Bacteroidaceae Infections / Q000382:microbiology*; D004195:Disease Models, Animal; D007249:Inflammation / Q000382:microbiology*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009055:Mouth / Q000382:microbiology; D016966:Porphyromonas gingivalis / Q000235:genetics / Q000254:growth & development*